User profiles for Minako Yamaoka
Minako Yamaoka-TojoKitasato University Verified email at med.kitasato-u.ac.jp Cited by 4268 |
Apoptosis in rat cardiac myocytes induced by Fas ligand: priming for Fas-mediated apoptosis with doxorubicin
M Yamaoka, S Yamaguchi, T Suzuki… - Journal of Molecular and …, 2000 - Elsevier
M. Yamaoka, S. Yamaguchi, T. Suzuki, M. Okuyama, J. Nitobe, N. Nakamura, Y. Mitsui and H.
Tomoike. Apoptosis in Rat Cardiac Myocytes Induced by Fas Ligand: Priming for Fas-…
Tomoike. Apoptosis in Rat Cardiac Myocytes Induced by Fas Ligand: Priming for Fas-…
Anti-inflammatory Cytokine Profile in Human Heart Failure Behavior of Interleukin-10 in Association With Tumor Necrosis Factor-Alpha
M Yamaoka, S Yamaguchi, M Okuyama… - Japanese circulation …, 1999 - jstage.jst.go.jp
Proinflammatory cytokines, ie, tumor necrosis factor-alpha (TNFα), participate in the
development and the progression of congestive heart failure (CHF). On the other hand, an anti-…
development and the progression of congestive heart failure (CHF). On the other hand, an anti-…
Elevated circulating levels and cardiac secretion of soluble Fas ligand in patients with congestive heart failure
S Yamaguchi, M Yamaoka, M Okuyama… - American Journal of …, 1999 - ajconline.org
Fas ligand (FasL) is a 40-kD type II transmembrane protein that is homologous to tumor
necrosis factor-(TNF-). 1 FasL induces apoptosis by binding to its membrane receptor Fas (CD95…
necrosis factor-(TNF-). 1 FasL induces apoptosis by binding to its membrane receptor Fas (CD95…
Serum levels of soluble form of Fas molecule in patients with congestive heart failure
…, S Yamaguchi, N Nozaki, M Yamaoka… - American Journal of …, 1997 - ajconline.org
Fas, also called APO-1, is a type I membrane protein of 45 kDa which is expressed in various
tissues and cells including the thymus, liver, ovary, lung, and heart. 1–3 Fas is a member of …
tissues and cells including the thymus, liver, ovary, lung, and heart. 1–3 Fas is a member of …
Role of gp91phox (Nox2)-Containing NAD(P)H Oxidase in Angiogenesis in Response to Hindlimb Ischemia
T Tojo, M Ushio-Fukai, M Yamaoka-Tojo, S Ikeda… - Circulation, 2005 - Am Heart Assoc
Background— Neovascularization is potentially important for the treatment of ischemic heart
and limb disease. We reported that reactive oxygen species (ROS) derived from gp91 phox (…
and limb disease. We reported that reactive oxygen species (ROS) derived from gp91 phox (…
IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species—dependent endothelial migration and …
M Yamaoka-Tojo, M Ushio-Fukai, L Hilenski… - Circulation …, 2004 - Am Heart Assoc
Endothelial cell (EC) proliferation and migration are important for reendothelialization and
angiogenesis. We have demonstrated that reactive oxygen species (ROS) derived from the …
angiogenesis. We have demonstrated that reactive oxygen species (ROS) derived from the …
JCS/JACR 2021 guideline on rehabilitation in patients with cardiovascular disease
…, N Suzuki, D Tamaki, M Yamaoka-Tojo… - Circulation …, 2022 - jstage.jst.go.jp
Eight years have passed since the publication of the only guideline on cardiac rehabilitation
(CR) in Japan,“Guidelines for rehabilitation in patients with cardiovascular disease (JCS …
(CR) in Japan,“Guidelines for rehabilitation in patients with cardiovascular disease (JCS …
Prediction of functional recovery in acute myocardial infarction: comparison between sestamibi reverse redistribution and sestamibi/BMIPP mismatch
…, H Atsumi, M Yamaki, N Takahashi, M Yamaoka… - Journal of Nuclear …, 1998 - Springer
Background It has been known that Tc 99m sestamibi/iodine 123
betamethyliodophenylpentadecanoic (123 I-BMIPP)(sestamibi/BMIPP) mismatch is an indicator of …
betamethyliodophenylpentadecanoic (123 I-BMIPP)(sestamibi/BMIPP) mismatch is an indicator of …
Gait speed has comparable prognostic capability to six-minute walk distance in older patients with cardiovascular disease
…, E Maekawa, C Noda, M Yamaoka-Tojo… - European Journal of …, 2018 - academic.oup.com
Background Although gait speed and six-minute walk distance are used to assess functional
capacity in older patients with cardiovascular disease, their prognostic capabilities have not …
capacity in older patients with cardiovascular disease, their prognostic capabilities have not …
[HTML][HTML] Endothelial glycocalyx damage as a systemic inflammatory microvascular endotheliopathy in COVID-19
M Yamaoka-Tojo - Biomedical journal, 2020 - Elsevier
In atherosclerosis patients, vascular endothelial dysfunction is commonly observed alongside
damage of the vascular endothelial glycocalyx, an extracellular matrix bound to and …
damage of the vascular endothelial glycocalyx, an extracellular matrix bound to and …